Worth Watching: Chemours Co’s Stock Is Buy After Today’s Huge Increase

Worth Watching: Chemours Co's Stock Is Buy After Today's Huge Increase

The stock of Chemours Co (NYSE:CC) is a huge mover today! About 1.44 million shares traded hands. Chemours Co (NYSE:CC) has risen 123.43% since March 15, 2016 and is uptrending. It has outperformed by 117.94% the S&P500.
The move comes after 5 months positive chart setup for the $2.97 billion company. It was reported on Oct, 18 by Barchart.com. We have $25.42 PT which if reached, will make NYSE:CC worth $1.75 billion more.

Analysts await Chemours Co (NYSE:CC) to report earnings on November, 3. They expect $0.26 EPS, down 35.00% or $0.14 from last year’s $0.4 per share. CC’s profit will be $48.29 million for 15.38 P/E if the $0.26 EPS becomes a reality. After $0.27 actual EPS reported by Chemours Co for the previous quarter, Wall Street now forecasts -3.70% negative EPS growth.

Chemours Co (NYSE:CC) Ratings Coverage

Out of 8 analysts covering Chemours (NYSE:CC), 3 rate it a “Buy”, 1 “Sell”, while 4 “Hold”. This means 38% are positive. Chemours has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. Susquehanna initiated the shares of CC in a report on Monday, July 27 with “Neutral” rating. JP Morgan upgraded the shares of CC in a report on Friday, August 7 to “Underweight” rating. The rating was upgraded by Argus Research on Wednesday, August 10 to “Buy”. Citigroup maintained it with “Neutral” rating and $8 target price in Monday, April 18 report. The firm has “Neutral” rating given on Friday, August 14 by Citigroup. The company was downgraded on Tuesday, August 18 by UBS. The rating was maintained by UBS on Tuesday, August 9 with “Sell”. Citigroup maintained the stock with “Neutral” rating in Thursday, August 11 report. As per Monday, March 14, the company rating was upgraded by Goldman Sachs. The rating was upgraded by JP Morgan to “Neutral” on Friday, August 7.

According to Zacks Investment Research, “Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company’s brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington.”

More important recent Chemours Co (NYSE:CC) news were published by: Fool.com which released: “Chemours Co Surges After New Jury Verdict” on July 08, 2016, also Valuewalk.com published article titled: “Chemours Co (CC) “Most Morally And Financially Bankrupt Company” Ever: Citron …”, Valuewalk.com published: “Chemours Co (CC) Starts To Rally After Tanking On Wednesday” on July 07, 2016. More interesting news about Chemours Co (NYSE:CC) was released by: Fool.com and their article: “Here’s Why Chemours Co Stock Popped Today” with publication date: February 24, 2016.

CC Company Profile

The Chemours Company, incorporated on February 18, 2014, is a well-known provider of performance chemicals. The Firm operates through three divisions: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment produces titanium dioxide (TiO2). The Company’s Fluoroproducts segment provides fluoroproducts, such as refrigerants and industrial fluoropolymer resins. The Company’s Chemical Solutions segment provides industrial and specialty chemicals used in gold production, oil refining, agriculture, industrial polymers and other industries. The Firm operates approximately 30 production facilities located in over 10 countries and serves a range of end markets in over 130 countries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Leave a Comment